follow
report
last
case
sever
acut
respiratori
syndrom
sar
epidem
juli
remark
progress
sever
area
research
molecular
identif
pathogen
pathogenesi
replic
genet
host
immunogen
well
eleg
epidemiolog
studi
sequenc
epidemiolog
event
unfold
earli
outbreak
gave
research
glimps
first
new
pathogen
era
global
year
drew
close
multipl
report
infecti
atyp
pneumonia
caught
public
health
offici
across
globe
surpris
suggest
new
human
pathogen
emerg
guangdong
provinc
china
end
februari
outbreak
sar
infect
almost
patient
caus
death
provinc
one
month
later
diseas
spread
throughout
asia
europ
north
america
epidem
eventu
affect
peopl
result
approxim
death
worldwid
mortal
rate
reach
certain
popul
electron
microscop
analysi
quickli
identifi
put
sar
agent
featur
associ
coronavirus
sar
agent
later
unambigu
identifi
new
coronaviru
member
name
sarscoronaviru
sarscov
coronavirus
envelop
plusstrand
rna
virus
largest
rna
genom
known
order
kb
coronavirus
long
import
world
veterinari
viral
diseas
howev
previous
known
human
coronavirus
caus
minor
health
problem
common
cold
gastrointestin
diseas
contrast
sarscov
pathogen
caus
fever
pulmonari
edema
diffus
alveolar
damag
sever
affect
individu
collect
term
sever
acut
respiratori
syndrom
sarscov
also
uniqu
coronaviru
date
member
known
caus
sever
morbid
mortal
human
demonstr
sarscov
caus
seriou
public
health
problem
focus
attent
need
understand
viral
replic
strategi
devis
prophylact
measur
clinic
symptom
sar
lower
respiratori
tract
infect
accompani
damag
lung
gastrointestin
involv
also
common
patient
present
wateri
diarrhea
fecal
sampl
sar
patient
taken
day
onset
diseas
contain
viral
rna
suggest
viral
shed
bowel
liver
dysfunct
also
report
base
observ
necrosi
hepatocyt
postmortem
tissu
examin
sar
patient
found
viru
presenc
lung
bowel
lymph
node
liver
heart
kidney
skelet
muscl
sampl
primari
mode
sarscov
transmiss
airborn
via
droplet
howev
also
report
presenc
replic
viru
blood
cell
peripher
blood
mononuclear
cell
small
larg
intestin
altern
mode
transmiss
bloodborn
fecalor
therefor
possibl
viru
isol
wild
anim
himalayan
palm
civet
raccoon
dog
found
anim
market
guangdong
china
actual
natur
reservoir
sarscov
still
unknown
transmit
human
sarscov
appear
evolv
facilit
humanhuman
transmiss
sequenc
analysi
differ
sarscov
isol
earli
epidem
show
delet
event
occur
open
read
frame
orf
ident
delet
orf
also
seen
anim
coronavirus
support
idea
sarscov
introduc
human
via
anim
intermedi
addit
delet
event
occur
earli
late
epidem
slow
missens
mutat
seen
time
extens
chang
occur
protein
earli
stage
outbreak
suggest
viru
undergon
level
adapt
ultim
stabil
time
epidem
sarscov
becom
virul
deciph
evolutionari
passag
viru
undoubtedli
provid
valuabl
inform
prevent
futur
outbreak
wake
sar
epidem
number
excel
review
articl
clinic
molecular
aspect
sar
epidemiolog
publish
review
focus
primarili
rapid
advanc
made
identif
character
sarscov
genom
well
describ
etiolog
viru
clinic
featur
diseas
sarscov
stori
enter
new
phase
search
prevent
strategi
cure
review
highlight
progress
made
reveal
molecular
aspect
sarscov
biolog
inform
may
lead
strategi
diseas
prevent
coronavirus
subdivid
three
group
base
genet
serolog
marker
group
ii
infect
mammal
group
iii
specif
avian
speci
group
member
porcin
transmiss
gastroenter
viru
tgev
epidem
diarrhea
viru
pedv
felin
canin
coronaviru
fcov
ccov
human
coronaviru
group
ii
includ
porcin
hemagglutin
encephalomyel
viru
hev
murin
hepat
viru
mhv
bovin
equin
rat
coronaviru
bcov
ecov
rtcov
human
coronaviru
group
iii
includ
turkey
coronaviru
tcov
pheasant
coronaviru
avian
infecti
bronchiti
viru
ibv
although
close
relat
group
ii
coronavirus
sarscov
uniqu
genet
featur
repres
distinct
phylogenet
group
date
approxim
sarscov
genom
sequenc
analyz
repres
differ
phase
epidem
earli
middl
late
two
isol
obtain
palm
civet
sarscov
genom
rna
approxim
kb
organ
open
read
frame
orf
sar
cov
structur
gene
arrang
follow
pattern
coronaviru
genom
replicas
orf
proteas
orf
spike
envelop
e
membran
nucleocapsid
n
howev
contrast
coronavirus
two
orf
unknown
function
locat
e
orf
orf
locat
n
addit
despit
evolutionari
overlap
sarscov
group
ii
coronaviru
genom
sequenc
sar
genom
lack
gene
hemagglutininesteras
protein
common
major
group
ii
coronavirus
excel
pictori
represent
sarscov
genom
function
lack
assign
orf
pleas
refer
recent
review
tan
et
al
signific
mileston
sarscov
molecular
biolog
construct
sarscov
fulllength
cdnacontain
plasmid
infecti
viral
rna
produc
develop
facilit
studi
sarscov
gene
function
promot
elucid
function
orf
whose
function
still
unknown
although
percept
orf
essenti
viral
replic
may
play
role
manifest
sever
diseas
rna
virus
util
varieti
mechan
exchang
genet
repertoir
viral
rna
depend
rna
polymeras
rdrp
built
error
rate
allow
diversif
genom
sequenc
replic
proce
estim
put
error
rate
rdrp
per
nucleotid
coronavirus
also
undergo
high
rate
rna
recombin
provid
addit
mechan
virus
rapidli
amplifi
genom
divers
sarscov
polymeras
gene
recombin
breakpoint
suggest
multipl
genet
origin
molecul
evolutionari
mechan
may
facilit
adapt
animalborn
sarscov
ancestor
human
host
suggest
event
futur
could
lead
viru
increas
pathogen
human
one
capabl
infect
multipl
speci
recent
evid
indic
humanadapt
sar
viru
cross
anoth
speci
sequenc
epidemiolog
analys
reveal
sarscov
isol
pig
deriv
human
strain
complet
nucleotid
sequenc
pig
viru
isol
design
tjf
genebas
phylogenet
tree
analysi
reveal
closer
relationship
human
sarscov
isol
anim
coronavirus
success
viral
replic
depend
upon
abil
viru
subvert
cellular
process
advantag
counteract
cellular
defens
mechan
viruscel
interact
repres
potenti
target
develop
virusspecif
antivir
drug
therapeut
prophylact
vaccin
differ
virus
base
target
cell
type
entri
pathway
differ
cellular
exploit
mechan
mechan
sar
viru
pathogenesi
vivo
may
reflect
effect
viral
replic
target
cell
host
immun
respons
molecular
basi
sarscov
replic
signal
pathway
affect
inflammatori
respons
provok
viral
infect
yet
clearli
understood
progress
area
lead
effect
prevent
strategi
counter
sarscov
infect
shown
sarscov
n
protein
select
activ
activ
signal
transduct
pathway
regul
wide
varieti
cellular
process
includ
cell
prolifer
differenti
apoptosi
viral
induc
modif
pathway
may
play
signific
role
viral
replic
strategi
recent
anoth
group
demonstr
protein
alon
induc
activ
region
amino
acid
within
protein
essenti
activationdepend
induct
anoth
sarscov
protein
orf
unknown
function
also
known
shown
produc
viru
infect
vero
cell
express
protein
alon
shown
induc
apoptosi
cell
cultur
rais
question
apoptosi
sarscov
infect
cell
balanc
order
viru
surviv
propag
figur
address
extent
recent
studi
indic
sarscov
infect
vero
cell
induc
proapoptot
activ
mitogenactiv
protein
kinas
mapk
antiapoptot
activ
protein
kinas
b
pkb
also
known
akt
signal
pathway
although
akt
induct
appear
insuffici
prevent
virusinduc
apoptosi
exactli
sarscov
manipul
cellular
signal
pathway
facilit
viral
replic
remain
determin
mention
induct
shown
depend
upon
activ
sarscov
protein
process
involv
may
partial
explain
clinic
observ
dramat
cytokin
storm
high
serum
level
inflamm
respons
observ
sar
patient
acut
stage
associ
lung
lesion
also
suggest
elev
due
sarscov
infect
respiratori
tract
induc
hyperinn
inflammatori
respons
establish
cellular
mapk
regul
activationdepend
induct
viral
infect
sarscov
infect
induct
signal
pathway
perhap
relat
angiotensinconvert
enzym
antibodi
inhibit
inductionreleas
cellular
receptor
sarscov
receptorbind
site
virion
locat
amino
acid
region
protein
coronaviru
genom
structur
major
geneproduct
function
known
year
sinc
caus
mild
diseas
select
virusspecif
antivir
drug
prioriti
past
sarscov
epidem
chang
select
view
tan
et
al
tabul
screen
avail
antivir
agent
sar
viru
detail
recent
review
obviou
molecular
target
sarscov
antivir
agent
viral
polymerasereplicas
proteas
receptor
viral
mrna
methyl
transferas
ntpasehelicas
addit
long
highli
conserv
rna
structur
untransl
region
coronavirus
astrovirus
identifi
structur
resembl
loop
rrna
involv
translat
initi
suggest
possibl
role
element
sequest
host
translat
machineri
tertiari
interact
structur
creat
tunnel
line
neg
charg
bind
uniqu
structur
present
attract
target
tunnel
bind
antivir
drug
final
sinc
function
detail
coronaviru
replicas
gene
product
known
random
screen
potenti
antivir
compound
librari
key
area
drug
discoveri
sar
viru
near
futur
takasuka
et
al
report
subcutan
administr
uvinactiv
purifi
sarscov
virion
elicit
high
level
humor
immun
result
longterm
antibodi
secret
memori
b
cell
antibodi
elicit
mice
recogn
spike
nucleocapsid
n
protein
viru
inactiv
viru
also
induc
region
lymph
node
tcell
prolifer
signific
level
cytokin
product
upon
restimul
inactiv
viru
vitro
studi
suggest
wholekil
virion
may
potenti
candid
antigen
sar
vaccin
elicit
humor
cellular
immun
sarscov
inactiv
betapropiolacton
use
antigen
mice
rabbit
anim
elicit
antibodi
receptorbind
domain
rbd
present
region
sarscov
antibodi
effect
inhibit
sprotein
mediat
sarspseudoviru
entri
suggest
potenti
inactiv
sarscov
antigen
vaccin
develop
deplet
rbdspecif
antibodi
patient
rabbit
immun
sera
immunoadsorpt
significantli
reduc
viru
neutral
abil
sera
suggest
rbd
epitop
protein
critic
determin
develop
vaccin
strategi
n
protein
sarscov
appear
conserv
protein
suggest
protein
may
play
role
cellmedi
immun
sarscov
infect
also
import
viral
antigen
earli
diagnosi
vaccin
mice
sarscov
n
protein
express
replicationdefect
human
adenoviru
vector
shown
produc
potent
sarscovspecif
humor
cellmedi
immun
respons
suggest
potenti
construct
use
sarscov
vaccin
along
line
intramuscular
immun
balbc
mice
plasmid
dna
construct
encod
fulllength
n
protein
shown
elicit
serum
antin
antibodi
spenocyt
prolif
respons
n
protein
immun
mice
also
produc
strong
delayedtyp
hypersensit
dth
ctl
respons
n
protein
suggest
n
protein
import
b
cell
immunogen
also
elicit
broadbas
cellular
immun
respons
anoth
novel
strategi
n
protein
express
cytoplasm
lactococcu
lacti
bacterium
nexpress
bacteria
administ
mice
intranas
oral
rout
case
signific
level
nspecif
igg
mice
sera
detect
suggest
engin
bacteria
may
serv
mucos
vaccin
sarscov
although
immun
inactiv
viral
vaccin
provid
signific
protect
anim
challeng
certain
correspond
pathogen
cov
case
sarscov
remain
threat
introduc
live
viru
environ
partial
inactiv
vaccin
valid
effect
inactiv
measur
develop
yet
circumv
obstacl
chen
et
al
introduc
protein
delet
iii
region
live
attenu
modifi
vaccinia
viru
ankara
mva
vector
recombin
viru
elicit
potent
neutral
antibodi
mice
rabbit
monkey
major
epitop
map
viru
receptorbind
region
anoth
approach
demonstr
coexpress
sarscov
n
express
plasmid
human
cell
result
format
sarscov
pseudoparticl
viruslik
particl
vlp
find
help
us
understand
viral
morphogenesi
well
offer
safer
altern
use
live
replic
sar
viru
develop
vaccin
third
possibl
genet
engin
version
live
sarscov
trait
attenu
phenotyp
increas
immunogen
safe
handl
facil
fulllength
sarscov
cdnacontain
plasmid
develop
synthet
infecti
viral
rna
produc
system
allow
function
analysi
gene
context
infect
use
make
attenu
strain
vaccin
develop
sarscov
clearli
pandem
potenti
although
progress
sarscov
molecular
cell
biolog
research
remark
remain
clear
limit
regard
vaccin
develop
due
lack
complet
understand
area
anim
model
diseas
well
host
immun
respons
evolv
molecular
divers
newli
emerg
human
viru
caution
warrant
util
experiment
data
origin
one
sarscov
strain
infect
one
anim
speci
cell
line
develop
human
vaccin
rapid
develop
effect
sarscov
vaccin
depend
upon
continu
basic
research
studi
evolv
protein
molecular
divers
sarscov
isol
unexpect
profound
immunofunct
effect
illustr
point
protein
exhibit
minor
genet
divers
among
strain
transmit
human
outbreak
earli
synthet
version
variant
human
prefer
codon
test
abil
bind
receptor
sensit
antibodi
neutral
viral
pseudotyp
set
experi
substanti
function
differ
found
deriv
guangdong
provinc
case
isol
two
palm
civet
isol
antibodi
neutral
human
isolatesderiv
protein
unexpectedli
enhanc
entri
mediat
civet
virusderiv
protein
novel
observ
emphas
need
understand
molecular
potenti
sarscov
genom
develop
vaccin
prevent
human
diseas
mention
previous
studi
also
point
fact
variabl
protein
earli
late
diseas
outbreak
stage
detect
larg
gap
understand
sarscov
interact
host
cell
rapidli
chang
genom
sarscov
indic
potenti
variabl
interact
develop
success
vaccin
sar
viru
therefor
depend
progress
make
area
immedi
futur
author
declar
compet
interest
author
contribut
equal
intellectu
content
review
articl
view
present
articl
necessarili
reflect
food
drug
administr
unit
state
govern
